Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("LOMAESTRO, Ben")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 20 of 20

  • Page / 1
Export

Selection :

  • and

Therapeutic interchange of fluoroquinolones at a medical centerLOMAESTRO, Ben M.American journal of health-system pharmacy. 2001, Vol 58, Num 10, pp 904-907, issn 1079-2082Article

Vancomycin-Associated Renal Dysfunction: Where Are We Now?CARRENO, Joseph J; KENNEY, Rachel M; LOMAESTRO, Ben et al.Pharmacotherapy. 2014, Vol 34, Num 12, pp 1259-1268, issn 0277-0008, 10 p.Article

Update on the pharmacotherapy of obesityCERULLI, Jennifer; LOMAESTRO, Ben M; MALONE, Margaret et al.The Annals of pharmacotherapy. 2007, Vol 41, Num 9, pp 1505-1517, issn 1060-0280, 13 p.Article

Piperacillin-Tazobactam for Pseudomonas aeruginosa Infection : Clinical Implications of an Extended-Infusion Dosing StrategyLODISE, Thomas P; LOMAESTRO, Ben; DRUSANO, George L et al.Clinical infectious diseases. 2007, Vol 44, Num 3, pp 357-363, issn 1058-4838, 7 p.Article

Pharmacodynamic evaluation of extending the administration time of meropenem using a Monte Carlo simulationLOMAESTRO, Ben M; DRUSANO, G. L.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 1, pp 461-463, issn 0066-4804, 3 p.Article

MenHibrix: A New Combination Meningococcal Vaccine for Infants and ToddlersHALE, Sarah F; CAMAIONE, Lauren; LOMAESTRO, Ben M et al.The Annals of pharmacotherapy. 2014, Vol 48, Num 3, pp 404-411, issn 1060-0280, 8 p.Article

Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of NephrotoxicityLODISE, Thomas P; LOMAESTRO, Ben; GRAVES, Jeffrey et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 4, pp 1330-1336, issn 0066-4804, 7 p.Article

Application of antimicrobial pharmacodynamic concepts into clinical practice: Focus on β-lactam antibiotics : Insights from the society of infectious diseases pharmacistsLODISE, Thomas P; LOMAESTRO, Ben M; DRUSANO, George L et al.Pharmacotherapy. 2006, Vol 26, Num 9, pp 1320-1332, issn 0277-0008, 13 p.Article

Bioterrorism: Pivotal clinical issues: Consensus review of the Society of Infectious diseases pharmacistsTERRIFF, Colleen M; SCHWARTZ, Mike D; LOMAESTRO, Ben M et al.Pharmacotherapy. 2003, Vol 23, Num 3, pp 274-290, issn 0277-0008, 17 p.Article

Vancomycin Dosing in Children and Young Adults: Back to the Drawing Board : VANCOMYCINCAMAIONE, Lauren; ELLIOTT, Kimberly; MITCHELL-VAN STEELE, Amy et al.Pharmacotherapy. 2013, Vol 33, Num 12, pp 1278-1287, issn 0277-0008, 10 p.Article

Integration of population pharmacokinetics, a pharmacodynamic target, and microbiologic surveillance data to generate a rational empiric dosing strategy for cefepime against Pseudomonas aeruginosaTAM, Vincent H; LOUIE, Arnold; LOMAESTRO, Ben M et al.Pharmacotherapy. 2003, Vol 23, Num 3, pp 291-295, issn 0277-0008, 5 p.Article

Effects of gatifloxacin and levofloxacin on rates of hypoglycemia and hyperglycemia among elderly hospitalized patientsLODISE, Thomas; GRAVES, Jeffrey; MILLER, Chris et al.Pharmacotherapy. 2007, Vol 27, Num 11, pp 1498-1505, issn 0277-0008, 8 p.Article

Progressive esophagitis caused by Candida albicans with reduced susceptibility to caspofunginMILLER, Christopher D; LOMAESTRO, Ben W; PARK, Steven et al.Pharmacotherapy. 2006, Vol 26, Num 6, pp 877-880, issn 0277-0008, 4 p.Article

Relationship between Initial Vancomycin Concentration-Time Profile and Nephrotoxicity among Hospitalized PatientsLODISE, Thomas P; PATEL, Nimish; LOMAESTRO, Ben M et al.Clinical infectious diseases. 2009, Vol 49, Num 4, pp 507-514, issn 1058-4838, 8 p.Article

Pharmacodynamic profiling of piperacillin in the presence of tazobactam in patients through the use of population pharmacokinetic models and Monte Carlo simulationLODISE, Thomas P; LOMAESTRO, Ben; RODVOLD, Keith A et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 12, pp 4718-4724, issn 0066-4804, 7 p.Article

Vancomycin: We Can't Get There From HerePATEL, Nimish; PAI, Manjunath P; RODVOLD, Keith A et al.Clinical infectious diseases. 2011, Vol 52, Num 8, pp 969-974, issn 1058-4838, 6 p.Article

Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistanceLODISE, Thomas P; MILLER, Christopher D; GRAVES, Jeffrey et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 2, pp 417-422, issn 0066-4804, 6 p.Article

Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections : Impact of delayed appropriate antibiotic selectionLODISE, Thomas P; PATEL, Nimish; KWA, Andrea et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 10, pp 3510-3515, issn 0066-4804, 6 p.Article

Therapeutic Monitoring of Vancomycin in Adults: Summary of Consensus Recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases PharmacistsRYBAK, Michael J; LOMAESTRO, Ben M; ROTSCHAFER, John C et al.Pharmacotherapy. 2009, Vol 29, Num 11, pp 1275-1279, issn 0277-0008, 5 p.Article

Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases PharmacistsRYBAK, Michael J; LOMAESTRO, Ben M; ROTSCHAFER, John C et al.Clinical infectious diseases. 2009, Vol 49, Num 3, pp 325-327, issn 1058-4838, 3 p.Article

  • Page / 1